Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Mitral Valve Regurgitation (Degenerative or Functional) clinical trials
1 of 2 indexed Mitral Valve Regurgitation (Degenerative or Functional) trials are currently recruiting.
Corpus placement: #7,188 of 28,707 conditions by registered trial count.
2 US clinical trials · 1 currently recruiting · #7,188 of 28,707 conditions by registered trial count
Mitral Valve Regurgitation (Degenerative or Functional): 2 US clinical trials tracked, 1 recruiting.
Mitral Valve Regurgitation (Degenerative or Functional) is the subject of 2 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. The most active sponsor is Edwards Lifesciences, running 2 of these trials.
Enrollment posture brief
Registry condition mitral-valve-regurgitation-degenerative-or-functional
OPEN 1 | RECR 50% | LATE 0 | EARLY 0 | RANK #7188 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Abdominal Aortic Aneurysms (50% recruiting · 6 trials)
Mitral Valve Regurgitation (Degenerative or Functional) lists 1 open slots (50% of 2 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Mitral Valve Regurgitation (Degenerative or Functional) on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Mitral Valve Regurgitation (Degenerative or Functional) is recruiting above its size-band peers.
1 of 2 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
2 total, page 1 of 1
Phase Distribution
Phase data not available
Top Sponsors
Named interventions
Most-linked intervention names on Mitral Valve Regurgitation (Degenerative or Functional) records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Mitral Valve Regurgitation (Degenerative or Functional) trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Mitral Valve Regurgitation (Degenerative or Functional) page
2 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Mitral Valve Regurgitation (Degenerative or Functional) trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Edwards Lifesciences sponsors the most Mitral Valve Regurgitation (Degenerative or Functional) trials on record, review their full trial history before evaluating a specific study. See Edwards Lifesciences's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Mitral Valve Regurgitation (Degenerative or Functional) condition card totals 2 registered trials; most-linked intervention Edwards EVOQUE Eos Mitral Valve Replacement System; top US site state Pennsylvania. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.